BERKELEY, Calif.--(BUSINESS WIRE)--May 10, 2006--XOMA Ltd. (NASDAQ:XOMA - News), a leader in the discovery and development of antibody therapeutics for cancer and immunological disorders, today announced its results for the first quarter ended March 31, 2006.
